Amer was Vice President, Disease Biology and Translational Sciences at Septerna, and Vice President, Biomarker Development at Ascendis Pharma. Amer Mirza joined Prolynx in 2026.
Amer Mirza is currently
Create your alert
to follow the career of Amer Mirza.
Amer Mirza has a Doctor of Philosophy in Hematology and Oncology from University of Toronto.
They have also studied at University of Toronto :
Find more alumni from University of Toronto
Do you need to know more about Amer Mirza? More results.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.